In March, Stuart Kurtz presented at the 2026 annual meeting of the Midwest Association of Toxicology and Therapeutic Drug Monitoring (MATT) on kratom products and how they’ve changed over the years. Previous blog posts have discussed mitragynine, kratom case reports,...
Axis toxicologists Laureen Marinetti, PhD, F-ABFT, and Stuart Kurtz, M.S, D-ABFT-FT, presented at the Midwest Association of Toxicology and Therapeutic Drug Monitoring (MATT) Annual Meeting in Cincinnati, Ohio, March 18-20, 2026. A recap and update of Dr....
By Kevin G. Shanks, D-ABFT-FT The term designer opioid generally refers to the class of synthetically derived opioid analogs that are intentionally modified by clandestine chemists to circumvent existing drug laws while maintaining opioid receptor activity. This...
By Laureen J. Marinetti, PhD, F-ABFT BTMPS (Bis[2,2,6,6-tetramethyl-4-piperidyl] sebacate), brand name Tinuvin®770, is commonly used in the manufacture of plastics as a UV-stabilizing additive to prevent degradation from sunlight and weather exposure. BTMPS was first...
By Kevin Shanks, D-ABFT-FT Stimulants come and go. New ones arrive on the illicit drug market all the time. One of the newest stimulants to be identified is MDPHP, also known as 3′,4′-Methylenedioxy-α-pyrrolidinohexiophenone. It is a substituted cathinone, a class of...
